Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF versus nanofat injection for scleroderma
IRCT20200127046282N35Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-blind trial of microfragmented adipose tissue in scleroderma (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Qualitative intensity of scleroderma and Quantitative intensity of scleroderma. Started Jun 2024; status: completed.
02
Drugs
microfragmented adipose tissue
03
Conditions
scleroderma
Beyond the preview
Go deeper on IRCT20200127046282N35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200127046282N35.